T oday's medicinal chemists and combinatorial chemistry groups require equipment that allows rapid organic synthesis in order to remain competitive in the race to discover new pharmaceuticals. First generation combinatorial chemistry systems are now being supplanted by more versatile and easy to use reactor systems. Some groups are focused on lead optimization, while others are focused on lead discovery. The requirements of these two groups are quite distinct: Lead optimization generally involves fewer reactions involving higher volumes of reactants (5-25ml), while lead discovery demands larger libraries involving smaller scale reactions (1-5ml). Modern automated synthetic hardware and software is being designed with the versatility required to accommodate both needs. Furthermore, both solid and solution based chemistry are used in pharmaceutical laboratories. However, earlier systems did not accommodate these seemingly contrasting methods of synthesis. By combining the ability to perform solid and liquid phase chemistries in one apparatus, as well as catering for the needs of combinatorial and medicinal chemists alike, the total cost for automated synthesis can be dramatically reduced.
Even greater levels of throughput can be achieved by taking advantage of the standard microplate format. By delivering into 96-well format, we are able to manipulate samples as arrays of 96 compounds rather than individually. However, a properly designed reactor should allow for smaller arrays, or individual sample manipulation by robot for post synthesis steps such as weighing and purity analysis.
The Mettler-Toledo Bohdan synthesis apparatus ( Figure 1 ) is our front cover feature for JALA. The MiniBlock™ Synthesizer, which was originally developed by Dr. Harold Weller and his team at the Bristol-Myers Squibb Pharmaceutical Research Institute, is now licensed to Bohdan and has many of the operational features that make it useful to a wide segment of the pharmaceutical chemist community. For example, the system accommodates the encoded trapped resins found in the "Irori MicroKan" process, which is used by combinatorial chemists to produce medium to large libraries. A discrete compound is synthesized in each MicroKan, which is subsequently placed in a 48 array MiniBlock and the resulting products are cleaved from the solid phase support into 48 or 96 format racks, using the special design of the Bohdan device (refer to Dr. Burt Goodman's article in this issue for more information).
The high throughput version of the Mettler-Toledo Bohdan synthesizer uses 48 fritted glass or custom molded polypropylene reaction tubes that can accommodate a 3 mL reaction. Under optimal conditions, this system will produce 40 mg of product for each position in a 96 well (Figure 1) .
Since the Mettler-Toledo Bohdan "MiniBlock Synthesizer" utilizes individual reaction tubes, it can also be configured with larger reaction tubes to produce up to 300 mg of product per position. Such formats are favored by medicinal chemists, who can develop and fine tune chemistries in the MiniBlock and then use the same blocks to produce larger libraries by switching to smaller reaction tubes as described above. In drug discovery, this has a significant advantage in that it provides a smooth and rapid transfer of methods from medicinal chemists to combinatorial chemists.
For more challenging reactions requiring heating or cooling, a modular heat transfer block is available to maintain all the reaction chambers within one degree Celcius over a wide range of temperatures. An inert gas manifold allows the addition of reagents under Argon into the reaction chamber through a laminated septum.
Robotic stations or liquid handlers from companies such as Metter-Toledo Bohdan can add liquids to MiniBlocks reactors housed on the robot bed and perform mapping functions ( Figure  3) . Reactors are moved to an orbital shaking station after liquid addition for vortex mixing and resin washing.
One of the innovative design features of the MiniBlock is the built-in valve assembly, which allows all reactions to be sealed or opened at the same time, by a simple key turn. This feature allows the direct delivery of reaction products in to automation friendly microplate formats. One such format is a rack containing 96 individual 2.5mL microtubes (Figure 4) . The use of discrete tubes offers two distinct advantages: product yield calculations and the reformatting or sorting of products, based on analytical data. The former is carried out by a robotic weighing workstation which automatically weighs 30 x 96 (2880) microtubes ( Figure 5) . Following screening, a different robotic reformatting station is able to sort tubes into categories such as those requiring screening, purification, or simply discarding due to insufficient quantity or purity and weigh 30 arrays in 24 hours. The robot is driven by a software system that can prevent sorting errors and maintain maximum efficiency.
Thus, the Bohdan MiniBlock approach can be used in two distinct ways, depending on the pharmaceutical companies' approach to drug discovery: Medicinal chemists can take advantage of the reactors as highly capable manual devices for developing chemistry protocols and then build libraries of diverse compounds. Or, the MiniBlocks can be totally integreated in the companies' workflow, whereby pre aud Post-synthesis steps are fully automated. It is clear that with either approach, the MiniBlock is proving to br a formidable tool for medicinal and combinatorial chemists alike. 
